PortViewPortView
Tenon Medical logo

Tenon Medical (TNONW) Stock Analysis

NASDAQHealthcareMedical - Care Facilities

$0.01-5.56%
1-year price historyRange $0.00 – $0.02
52-week range$0.01
$0.00$0.04

Track TNONW in your portfolio for free · Portfolio tracker

What Tenon Medical does

Tenon Medical, Inc. is a medical device company, which engages in the development of a minimally invasive approach to the sacroiliac joint (SI joint) using a single titanium implant for treatment of the most common types of SI Joint disorders. The company was founded by Richard Ferrari and Richard Ginn on June 19, 2012 and is headquartered in Los Gatos, CA.

Key metrics

Market cap
$5,266
EPS (TTM)
$-47.46
Beta
3.63
50-day avg
$0.01
200-day avg
$0.01
52-week high
$0.04
52-week low
$0.00
CEO
Steven Foster

ETFs linked to TNONW

Broad-market and Healthcare sector ETFs an investor holding Tenon Medical is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TNONW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TNONW in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Tenon Medical?
Tenon Medical trades under the ticker TNONW on NASDAQ.
Which exchange is TNONW listed on?
TNONW is listed on NASDAQ.
What sector does Tenon Medical operate in?
Tenon Medical is classified in the Healthcare sector (Medical - Care Facilities industry).
How can PortView help analyze TNONW in a portfolio?
PortView shows TNONW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.